ANGIODYNAMICS, INC. FDA Inspection Record
ANGIODYNAMICS, INC. is an FDA-registered facility (FEI 1319211) located in Queensbury, NY, US. RegDataLab tracks 7 FDA inspections and 2 compliance actions at this facility.
What FDA found at this site
- Latest inspection
- Jan 10, 2025: Voluntary Action Indicated (VAI)
- Inspections on record
- 7 (4 OAI, 3 VAI)
- Last OAI inspection
- Feb 4, 2014
- Warning letters
- 2 listed by FDA for this FEI, latest May 27, 2011
- Recalls as the recalling firm
- 22, latest Mar 3, 2026
- Import refusals
- 3
Inspections and what FDA cited
| Date | Result | What FDA cited |
|---|---|---|
| Jan 10, 2025 | Voluntary Action Indicated (VAI) | Lack of or inadequate complaint procedures (21 CFR 820.198(a)) Records of complaint investigation (21 CFR 820.198(e)) |
| Apr 21, 2016 | Voluntary Action Indicated (VAI) | Design input - documentation (21 CFR 820.30(c)) Lack of or inadequate procedures (21 CFR 820.100(a)) Availability (21 CFR 820.180) DHR content (21 CFR 820.184) and 2 more |
| Feb 4, 2014 | Official Action Indicated (OAI) | Lack of or inadequate complaint procedures (21 CFR 820.198(a)) |
| Sep 24, 2012 | Official Action Indicated (OAI) | No citations listed |
| Feb 10, 2012 | Official Action Indicated (OAI) | Lack of or inadequate procedures for distribution (21 CFR 820.160(a)) Incorrect translation to production specifications (21 CFR 820.30(h)) Training - Lack of or inadequate procedures (21 CFR 820.25(b)) Lack of or inadequate procedures - Acceptance activities (21 CFR 820.80(a)) and 8 more |
| Jan 13, 2011 | Official Action Indicated (OAI) | Design input - documentation (21 CFR 820.30(c)) Review and evaluation for investigation (21 CFR 820.198(b)) Report of risk to health (21 CFR 806.10(a)(1)) Lack of System for Event Evaluations (21 CFR 803.17(a)(1)) |
| Dec 16, 2009 | Voluntary Action Indicated (VAI) | Design output procedures (21 CFR 820.30(d)) Design validation- Lack of or inadequate procedures (21 CFR 820.30(g)) Control/distribution procedures (21 CFR 820.160(a)) Equipment suitability & capability (21 CFR 820.72(a)) and 8 more |
Recalls
| Date | Class | Recall | Product and reason |
|---|---|---|---|
| Mar 3, 2026 | Class II | Z-1856-2026 | Soft-Vu Angiographic Catheter, Pigtail, Non-Braided;
SOFT-VU PT 4F X 100CM 035 NB… and 19 more products The affected devices contain a manufacturing defect which may prevent the appropriately sized guidewire from passing through the inner… |
| Feb 4, 2025 | Class II | Z-1391-2025 | IsoLoc Short Profile Prostate Immobilization Treatment Balloon Device Kit; UPN/Catalog… Product is mislabeled with the incorrect fill volume. |
| Nov 25, 2024 | Class II | Z-0770-2025 | AURYON LASER SYSTEM 100-120 VAC. Model Number: EXM001. Product Number: EXM-2001-1100 Potential for procedural delays or interruptions during use of the Auryon Atherectomy System due to the Auryon Atherectomy System not… |
| Jun 18, 2024 | Class II | Z-2453-2024 | SOFT-VU KUMPE 5F X 40CM -Used for patients in need of angiographic diagnosis.
Catalog… and 1 more product Mislabeled. The shelf-box labeling (unit of sale) is accurate for the packaged devices, however the inner pouch label may contain… |
| May 21, 2024 | Class II | Z-2267-2024 | IsoLoc Prostate Immobilization Treatment Balloon Device Kit, Catalog/UPN: ISO-100 A single batch of ISO-100 IsoLoc Gas-Release Endorectal Balloons is mislabeled. The affected ISO-100 balloon catheter has a nominal fill… |
| Mar 18, 2024 | Class II | Z-1760-2024 | DURAFLOW 2, 24CM STRAIGHT BASIC KIT -Indicated for use in attaining Long-Term vascular… and 14 more products Tri-Ball Tunneler may contain loosely affixed metal shavings, potential for the metal shaving to embolize, possibly requiring removal via… |
| Jan 30, 2024 | Class II | Z-1334-2024 | MINI STICK MAX 4F X 10 CM STD .018 SS/PD ECHO 2.75" PG-Used for the percutaneous… and 14 more products Non-conformance may prevent the guidewire from passing through the introducer hub during a surgical procedure. The inability of the… |
| Dec 18, 2023 | Class II | Z-1010-2024 | PulseSpray Infusion System devices including: PULSE SPRAY 5F/135/20, UPN: H787125004045… Rotating adaptor O-ring manufacturing defect impacting seal integrity which may lead to a leak during infusion of medication. |
| Mar 2, 2023 | Class II | Z-1381-2023 | NanoKnife 5-Probe Procedure Pack 15 cm - Activation. Indicated for the surgical ablation… Not programmed in accordance with specification. The programming affects the RFID function and does not allow the NanoKnife probes to be… |
| Sep 20, 2022 | Class II | Z-0132-2023 | Vortex MP Port Titanium Low Profile Implanted Port with 5F attached Silicone Catheter and… Printed Instructions for Use (IFU) not shipped with device. The Instructions for Use contain the Warnings, Precautions, Contraindications… |
FDA record score
45 of 100. A count of this site's adverse public FDA records, weighted by how recent each one is. A higher number means more, or more recent, records. Each record below adds the points shown.
31 records behind this number
| Record | Date | Points x age weight | Adds |
|---|---|---|---|
| Inspection classified VAI | Jan 10, 2025 | 6 x 1 | 6 |
| Class II recall Z-1856-2026, this FEI as the recalling firm | Mar 3, 2026 | 4 x 1 | 4 |
| Class II recall Z-1391-2025, this FEI as the recalling firm | Feb 4, 2025 | 4 x 1 | 4 |
| Class II recall Z-0770-2025, this FEI as the recalling firm | Nov 25, 2024 | 4 x 1 | 4 |
| Class II recall Z-2453-2024, this FEI as the recalling firm | Jun 18, 2024 | 4 x 0.6 | 2.4 |
| Class II recall Z-2267-2024, this FEI as the recalling firm | May 21, 2024 | 4 x 0.6 | 2.4 |
| Class II recall Z-1760-2024, this FEI as the recalling firm | Mar 18, 2024 | 4 x 0.6 | 2.4 |
| Class II recall Z-1334-2024, this FEI as the recalling firm | Jan 30, 2024 | 4 x 0.6 | 2.4 |
| Class II recall Z-1010-2024, this FEI as the recalling firm | Dec 18, 2023 | 4 x 0.6 | 2.4 |
| Class II recall Z-1381-2023, this FEI as the recalling firm | Mar 2, 2023 | 4 x 0.6 | 2.4 |
| Class II recall Z-0132-2023, this FEI as the recalling firm | Sep 20, 2022 | 4 x 0.6 | 2.4 |
| Class II recall Z-1819-2022, this FEI as the recalling firm | Aug 10, 2022 | 4 x 0.6 | 2.4 |
| Class II recall Z-2436-2021, this FEI as the recalling firm | Jul 20, 2021 | 4 x 0.25 | 1 |
| Class II recall Z-0418-2021, this FEI as the recalling firm | Oct 14, 2020 | 4 x 0.25 | 1 |
| Class II recall Z-2395-2020, this FEI as the recalling firm | May 4, 2020 | 4 x 0.25 | 1 |
| Class II recall Z-0073-2022, this FEI as the recalling firm | Apr 24, 2020 | 4 x 0.25 | 1 |
| Class II recall Z-0709-2020, this FEI as the recalling firm | Nov 19, 2019 | 4 x 0.25 | 1 |
| Class II recall Z-2444-2019, this FEI as the recalling firm | Jun 27, 2019 | 4 x 0.25 | 1 |
| Class II recall Z-0742-2018, this FEI as the recalling firm | Sep 22, 2017 | 4 x 0.25 | 1 |
| Class II recall Z-0526-2018, this FEI as the recalling firm | Jun 5, 2017 | 4 x 0.25 | 1 |
| Class II recall Z-0772-2017, this FEI as the recalling firm | Sep 28, 2016 | 10 years or older, so it adds no points | 0 |
| Inspection classified VAI | Apr 21, 2016 | 10 years or older, so it adds no points | 0 |
| Class II recall Z-2260-2014, this FEI as the recalling firm | Aug 6, 2014 | 10 years or older, so it adds no points | 0 |
| Inspection classified OAI | Feb 4, 2014 | 10 years or older, so it adds no points | 0 |
| Class II recall Z-1405-2013, this FEI as the recalling firm | Apr 30, 2013 | 10 years or older, so it adds no points | 0 |
| Inspection classified OAI | Sep 24, 2012 | 10 years or older, so it adds no points | 0 |
| Inspection classified OAI | Feb 10, 2012 | 10 years or older, so it adds no points | 0 |
| Warning letter on FDA's dashboard, which does not show close-outs | May 27, 2011 | 10 years or older, so it adds no points | 0 |
| Warning letter on FDA's dashboard, which does not show close-outs | Jan 21, 2011 | 10 years or older, so it adds no points | 0 |
| Inspection classified OAI | Jan 13, 2011 | 10 years or older, so it adds no points | 0 |
| Inspection classified VAI | Dec 16, 2009 | 10 years or older, so it adds no points | 0 |
When each source was last refreshed
| Records | Last refreshed | Source as of | Status |
|---|---|---|---|
| Inspections | Nov 22, 2026 | Newest record Nov 9, 2026 | Current |
| Inspection citations | Nov 22, 2026 | Newest record Nov 5, 2026 | Current |
| Compliance actions (warning letters, injunctions and other action types) | Nov 22, 2026 | Newest record Nov 13, 2026 | Current |
| Warning letter text | Nov 22, 2026 | Newest record Nov 17, 2026 | Current |
| Recalls (Enforcement Report) | Nov 22, 2026 | Newest record Nov 18, 2026 | Current |
| Form 483s and inspection documents | Nov 18, 2026 | Newest record Nov 17, 2026 | Current |
| Import refusals | Nov 22, 2026 | Newest record Nov 12, 2026 | Current |
Reviewing ANGIODYNAMICS, INC. as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.
Or check ANGIODYNAMICS, INC. yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.
Facility details
- Company
- Angiodynamics, Inc.
- Location
- Queensbury, NY (US)
- Source
- device